Ionizing radiation and genetic risks X. The potential 'disease phenotypes' of radiation-induced genetic damage in humans: Perspectives from human molecular biology and radiation genetics

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 429, Issue 1, 1999, Pages 45-83

  Sankaranarayanan, K ^a  

^a MGC   (Netherlands)

Author keywords

Genetic risk; Phenotype; Radiation

Indexed keywords

GENE DELETION; GENETIC DISORDER; GENETIC RISK; GENOTOXICITY; HUMAN; IONIZING RADIATION; MUTATION; MUTATION RATE; PHENOTYPE; PRIORITY JOURNAL; RADIATION; RADIATION RESPONSE; REVIEW;

EID: 0032856296     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(99)00100-1     Document Type: Article

References (266)

1. NAS, The BEIR V Report. Health Effects of Exposure to Low levels of Ionizing Radiation, National Academy of Sciences-National Research Council, Washington, DC, 1990.
2. UNSCEAR, United Nations Scientific Committee on the Effects of Atomic Radiation, The 1993 Report to the General Assembly with Scientific Annexes, United Nations, New York, 1993.
3. Chakraborty R., Yasuda N., Denniston C., Sankaranarayanan K. Ionizing radiation and genetic risks: VII. The concept of mutation component and its use in risk estimation for Mendelian diseases. Mutat. Res. 400:1998;541-552.
4. Denniston C., Chakraborty R., Sankaranarayanan K. Ionizing radiation and genetic risks: VIII. The concept of mutation component and its use in risk estimation for multifactorial diseases. Mutat. Res. 405:1998;57-79.
5. Sankaranarayanan K. Environmental mutagens and genetic risks: lessons from radiation genetics. Environ. Mol. Mutagen. 28:1996;65-70.
6. Sankaranarayanan K. Ionizing radiation and genetic risks: IX. Estimates of the frequencies of Mendelian disease and spontaneous mutation rates in human populations: a 1998 perspective. Mutat. Res. 411:1998;129-178.
7. Neel J.V., Schull W.J., Awa A.A.et al. The children of parents exposed to atomic bombs: estimates of the genetic doubling dose of radiation for humans. Am. J. Hum. Genet. 46:1990;1053-1072.
8. Otake M., Schull W.J., Neel J.V. Congenital malformations, stillbirths and early mortality among the children of atomic bomb survivors. Radiat. Res. 122:1990;1-11.
9. Czeizel A.E., Elek C., Susanszky E. The evaluation of the germinal mutagenic impact of Chernobyl radiological contamination in Hungary. Mutagenesis. 6:1991;285-288.
10. Little J. The Chernobyl accident, congenital anomalities and other reproductive outcomes. Pediatr. Perinat. Epidemiol. 7:1993;121-151.
11. Byrne J., Rasmussen S.A., Steinhorn S.C.et al. Genetic disease in offspring of long-term survivors of childhood and adolescent cancer. Am. J. Hum. Genet. 62:1998;45-52.
12. Källen B., Karlsson P., Lundell M.et al. Outcome of reproduction in women irradiated for skin hemangiomas in infancy. Radiat. Res. 149:1998;202-208.
13. Sankaranarayanan K. Ionizing radiation and genetic risks: IV. Current methods, estimates of risk of Mendelian disease, human data and lessons from biochemical and molecular studies of mutations. Mutat. Res. 258:1991;99-122.
14. Sankaranarayanan K. Ionizing radiation, genetic risk estimation and molecular biology: impact and inferences. Trends Genet. 9:1993;79-84.
15. D.N. Cooper, M. Krawczak, Human Gene Mutation, BIOS Scientific Publishers, Oxford, 1993.
16. Lalioti M.D., Scott H.S., Buresi C.et al. Dodecamer repeat expansion in cystatin B gene in progressive myclonus epilepsy. Nature. 386:1997;847-851.
17. E.M. Rinchik, L.B. Russell, Germ-line deletion mutations in the mouse: tools for intensive functional and physical mapping of regions of the mammalian genome, in: K.E. Davies, S.M. Tilghman (Eds.), Genome Analysis, Genetic and Physical Mapping, Vol. 1, Cold Spring Harbor Laboratory Press, New York, 1990, pp. 121-158.
18. Sankaranarayanan K. Ionizing radiation and genetic risks. II. Nature of radiation-induced mutations in experimental mammalian in vivo systems. Mutat. Res. 258:1991;51-73.
19. Sankaranarayanan K. Ionizing radiation and genetic risks: III. Nature of spontaneous and radiation-induced mutations in mammalian in vitro systems and mechanisms of induction of mutations by radiation. Mutat. Res. 258:1991;75-97.
20. Thacker J. Radiation-induced mutations in mammalian cells at low doses and dose-rates. Adv. Radiat. Biol. 16:1992;77-124.
21. Bellus G.A., Hefferson T.W., Rosa I.et al. Achondroplasia is defined by recurrent mutations of FGFR3. Am. J. Hum. Genet. 56:1995;368-373.
22. Kunkel T.A. Mutational specificity of depurination. Proc. Nat. Acad. Sci. USA. 81:1984;1494-1498.
23. Kunkel T.A., Alexander P.S. The base substitution fidelity of eukaryotic DNA polymerases. J. Biol. Chem. 261:1986;160-166.
24. Loeb L.A. Apurinic sites as mutagenic intermediates. Cell. 40:1985;483-484.
25. Purandare S.M., Patel P.I. Recombination hot spots and human disease. Genome Res. 7:1997;773-786.
26. Dutly F., Schinzel A. Unequal interchromosomal rearrangements may result in elastin gene deletions causing the Williams-Beuren syndrome. Hum. Mol. Genet. 5:1996;1893-1898.
27. Chen K.S., Manian P., Koeth T.et al. Homologous recombination of a flanking repeat gene cluster is a mechanism for a common contiguous gene deletion syndrome. Nat. Genet. 17:1997;154-163.
28. Perez-Jurado L.A., Wang Y.K., Peoples R.et al. A duplicated gene in the breakpoint regions of the 7q11.23 Williams-Beuren syndrome deletion encodes the initiator binding protein TFII-I and BAP-135 phosphorylation target of BTK. Hum. Mol. Genet. 7:1998;325-334.
29. Baumer A., Dutly F., Balmer D.et al. High levels of unequal meiotic crossovers at the origin of the 22q11.2 and 7q11.23 deletions. Hum. Mol. Genet. 7:1998;887-894.
30. Lupski J.R. Genomic disorders: structural features of the genome can lead to DNA rearrangements and human disease traits. Trends Genet. 14:1998;417-422.
31. McTaggart K.E., Budarf M.L., Driscoll D.A.et al. Cat eye syndrome chromosome breakpoint clustering: identification of two intervals also associated with 22q11 deletion syndrome breakpoints. Cytogenet. Cell Genet. 81:1998;222-228.
32. Edelmann L., Pandita R.K., Morrow B.E. Low-copy repeats mediate the common 3-Mb deletion in patients with velo-cardio-facial syndrome. Am. J. Hum. Genet. 64:1999;1076-1086.
33. Ledbetter D.H., Engel E. Uniparental disomy in humans: development of an imprinting map and its implications for prenatal diagnosis. Hum. Mol. Genet. 4:1995;1757-1764. Review.
34. Engel E. Uniparental disomies in unselected populations. Am. J. Hum. Genet. 63:1998;962-966.
35. Morison I.M., Reeve A.E. A catalogue of imprinted genes and parent of origin effects in humans and animals. Hum. Mol. Genet. 7:1998;1599-1609. Review.
36. Kazazian H.H. Mobile elements and disease. Curr. Opin. Genet. Dev. 8:1998;343-350.
37. Russell W.L., Russell L.B. The genetic and phenotypic characteristics of radiation-induced mutations in mice. Radiat. Res. 1:1959;296-305. supplement.
38. Russell W.L. The nature of the dose-rate effect of radiation on mutation in mice. Jpn. J. Genet. 40:1965;128-140. supplement.
39. Lyon M.F., Morris T. Gene and chromosome mutation after large fractionated or unfractionated radiation doses to mouse spermatogonia. Mutat. Res. 8:1969;191-198.
40. Kohn H.I., Melvold R.W. Divergent X-ray-induced mutation rates in the mouse for the H and "7-locus" groups of loci. Nature. 259:1976;209-210.
41. Kohn H.I., Melvold R.W., Dunn G. Failure of X-rays to mutate class II histocompatibility loci in BALB/c mouse spermatogonia. Mutat. Res. 37:1976;237-244.
42. Arlett C.F., Turnbull D., Harcourt S.A.et al. A comparison of the 8-azaguanine and ouabain-resistance systems for the selection of induced mutant Chinese hamster calls. Mutat. Res. 33:1975;261-278.
43. Thacker J., Stephens M.A., Stretch A. Mutation to ouabain resistance in Chinese hamster cells: induction by ethylmethane suphonate and lack of induction by ionizing radiation. Mutat. Res. 51:1978;255-270.
44. Holmquist G.P. Chromosomal bands, their chromatin flavors and their functional significance. Am. J. Hum. Genet. 51:1992;17-37.
45. A. Schinzel V.A. McKusick, C. Francomano, P.L. Pearson, Report of the Committee for clinical disorders and chromosome aberrations, in: A.L. Cuticchia, P.L. Pearson (Eds.), Human Gene Mapping 1993, Johns Hopkins, Baltimore, 1994, pp. 735-772.
46. Wolf U. Identical mutations and phenotypic variation. Hum. Genet. 100:1997;305-321.
47. Bridges B.A. Spontaneous mutations: some conceptual difficulties. Mutat. Res. 304:1984;13-17.
48. Johnson D.K., Stubbs L.J., Culiat C.T.et al. Molecular analysis of 36 mutations at the mouse pink-eyed dilution (p) locus. Genetics. 141:1995;1563-1571.
49. Russell L.B., Montgomery C.S., Cacheiro N.L.A., Johnson D.K. Complementation analysis for 45 mutations encompassing the pink-eyed dilution (p) locus of the mouse. Genetics. 141:1995;1547-1562.
50. Metallinos D.L., Oppenheimer A.J., Rinchik E.M.et al. Fine structure mapping and deletion analysis of the murine piebald locus. Genetics. 136:1994;217-223.
51. Rinchik E.M. Molecular genetics of the brown (b) locus region of the mouse chromosome 4: II. Complementation analysis of lethal brown deletions. Genetics. 137:1994;855-865.
52. Rinchik E.M., Stoye J.P., Frankel W.N.et al. Molecular analysis of viable spontaneous and radiation-induced albino (c) locus mutations in the mouse. Mutat. Res. 286:1993;199-207.
53. L.B. Russell, Information from specific-locus mutants on the nature of induced and spontaneous mutations in the mouse. In: C. Ramel, et al. (Eds.), Genetic Toxicology of Environmental Chemicals, Part B, Genetic Effects and Applied Mutagenesis, Liss, New York, 1986, pp. 437-447.
54. T. Strachan, A.P. Read, Human Molecular Genetics, BIOS Scientific Publishers, Oxford, 1996.
55. Kacser H., Burns J.A. The molecular basis of dominance. Genetics. 97:1981;639-666.
56. P.H. Byers, Osteogenesis imperfecta, in: P.M. Royce, B. Steinmann (Eds.), Connective Tissue and its Heritable Disorders, Wiley-Liss, New York, 1993, pp. 317-350.
57. B.Steinmann, P.M. Royce, A. Superti-Furga, The Ehlers-Danlos syndrome, in: P.M. Royce, B. Steinmann (Eds.), Connective Tissue and its Heritable Disorders, Wiley-Liss, New York, 1993, pp. 351-407.
58. Ehling U.H. The frequency of X-ray-induced dominant mutations affecting the skeleton in mice. Genetics. 51:1965;723-732.
59. Ehling U.H. Dominant mutations affecting the skeleton in offspring of X-irradiated male mice. Genetics. 54:1966;1381-1389.
60. Selby P.B., Selby P.R. Gamma-ray-induced dominant mutations that cause skeletal abnormalities in mice: I. Plan, summary of results and discussion. Mutat. Res. 43:1977;357-375.
61. Selby P.B., Selby P.R. Gamma-ray-induced dominant mutations that cause skeletal abnormalities in mice: II. Description of proved mutations. Mutat. Res. 50:1978;341-351.
62. Favor J. Risk estimation based on germ cell mutations in animals. Genome. 31:1989;844-852.
63. Yoshimoto Y., Neel J.V., Schull W.J.et al. Malignant tumors during the first two decades of life in the offspring of atomic bomb survivors. Am. J. Hum. Genet. 46:1990;1041-1052.
64. Mulvihill J.J., Czeizel A. Perspectives in mutation epidemiology, 6: a 1993 view of sentinel phenotypes. Mutat. Res. 123:1983;345-361.
65. Warburton D., Fraser F.C. Spontaneous abortion risks in man: data from reproductive histories collected in a medical genetics unit. Am. J. Hum. Genet. 16:1964;1-27.
66. F.D. Abramson, Spontaneous fetal death in man, A methodological and analytical evaluation, PhD disseration, University of Michigan, Ann Arbor, MI, 1971.
67. Edmonds K., Lindsay K.S., Miller J.F.et al. Early embryonic mortality in women. Fertility and Sterility. 38:1982;447-453.
68. K. Sperling, Frequency and origin of chromosome abnormalities in man, in: G. Obe (Ed.), Mutation in Man, Springer, Berlin, 1984, pp. 128-146.
69. Wilcox A.J., Weinberg C.R., Clarice R.et al. Incidence of early losses in pregnancy. New Engl. J. Med. 319:1988;189-194.
70. Schmickel R.D. Contiguous gene syndromes: a component of recognizable syndromes. J. Pediatr. 109:1986;231-241.
71. Budarf M.L., Emanuel B.S. Progress in the autosomal segmental aneusomy syndromes (SASs): single or multilocus disorders? Hum. Mol. Genet. 6:1997;1657-1665. Review.
72. Ballabio A., Andria G. Deletions and translocations involving the distal short arm of the human X chromosome: review and hypotheses. Hum. Mol. Genet. 1:1992;221-227.
73. Schinzel A. Microdeletion syndromes, balanced translocations and gene mapping. J. Med. Genet. 25:1988;454-462.
74. Epstein C.J. Mechanisms of the effects of aneuploidy in mammals. Ann. Rev. Genet. 22:1988;51-75.
75. Epstein C.J. The new dysmorphology: application of insights from basic developmental biology to the understanding of human birth defects. Proc. Nat. Acad. Sci USA. 92:1995;8566-8573.
76. M. Baraitser, R.M. Winter, Color Atlas of the Congenital Malformation Syndromes, Mosby-Wolfe, London, 1996.
77. Brewer C., Holloway S., Zawalnyski P.et al. A chromosomal deletion map of human malformations. Am. J. Hum. Genet. 63:1998;1153-1159.
78. Jacobs P.A. Correlation between euploid structural chromosome rearrangments and mental subnormality in humans. Nature. 249:1974;164-165.
79. W.R. Breg, Euploid structural rearrangements in the mentally retarded, in: E.B. Hook, I.H. Porter (Eds.), Population Cytogenetics: Studies in Humans, Academic Press, New York, 1977, pp. 99-101.
80. Funderburk J., Spence M.A., Sparkes R.S. Mental retardation with balanced chromosomal rearrangements. Am. J. Hum. Genet. 29:1977;136-141.
81. S.R. Patil, H.A. Lubs, W.J. Kimberling, et al., Chromosomal abnormalities ascertained in a collaborative survey of 4343 seven and 8-year-old children: frequency, phenoytpe and epidemiology, in: E.B. Hook, I.H. Porter (Eds.), Population Cytogenetics: Studies in Humans, Academic Press, New York, 1977, pp. 103-131.
82. Tharapel A.T., Summit R.L., Wilroy R.S.et al. Apparently balanced de novo translocations in patients with abnormal phenotypes, report of six cases. Clin. Genet. 8:1977;255-269.
83. Fryns J.P., van den Berghe H. Possible excess of mental handicap and congenital malformations in autosomal reciprocal translocations. Annals de Genetique. 22:1979;125-127.
84. Aurias A., Prieur M., Dutrillaux B.et al. Systematic analysis of 95 reciprocal translocations of autosomes. Hum. Genet. 45:1978;259-282.
85. Claire D.St., Blackwood D., Muir W.et al. Association within a family of a balanced autosomal translocation with major mental illness. Lancet. 336:1990;13-16.
86. Farrell S.A., Fan Y.S. Balanced non-acrocentric whole-arm reciprocal translocations: a de novo case and literature review. Am. J. Med. Genet. 55:1995;423-426.
87. Madan K. Parcentric inversions: a review. Hum. Genet. 96:1995;503-515.
88. Pettenati M.J., Rao P.N., Phelan M.C.et al. Paracentric inversions in humans: A review of 446 paracentric inversions with presentation of 120 new cases. Am.J. Med. Genet. 55:1995;171-187.
89. Cohen O., Cans C., Cuillet M.et al. Cartographic study: breakpoints in 1574 families carrying human reciprocal translocations. Hum. Genet. 97:1996;659-667.
90. A. Schinzel, V.A. McKusick, C. Francomano, P.L. Pearson, Report of the committee for clinical disorders and chromosome aberrations, in: A.J. Cuticchia, P.L. Pearson (Eds.), Human Gene Mapping 1993, Johns Hopkins, Baltimore, 1994, pp. 735-772.
91. A. Schinzel, V.A. McKusick, C. Francomano, Report of the committee for clinical disorders and chromosome aberrations, in: A.J. Cuticchia, et al. (Eds.), Human Gene Mapping 1995, Johns Hopkins, Baltimore, 1996, pp. 1409-1453.
92. Kleinjan D.J., van Heyningen V. Position effect in human genetic disease. Hum. Mol. Genet. 7:1998;1611-1618. Review.
93. Weiler K.S., Wakimoto B.T. Heterochromatin and gene expression in Drosophila. Ann. Rev. Genet. 29:1995;577-605.
94. Barber J.C.K., Joyce C.A., Collinson M.N.et al. Duplication of 8p23.1: a cytogenetic anomaly with no established clinical significance. J. Med. Genet. 35:1998;491-496.
95. Kratochvilova J., Ehling U.H. Dominant cataract mutations induced by γ-irradiation of male mice. Mutat. Res. 63:1979;221-223.
96. U.H. Ehling, Induction and manifestation of hereditary cararacts, in: A.D. Woodhead, et al. (Eds.), Assessment of low risk from low level exposure to radiation and chemicals: a critical overview, Plenum, New York, 1985, pp. 345-367.
97. T. Nomura, Changed urethane and radiation response of the mouse germ cells to tumour induction, in: L. Severi (Ed.), Tumours of Early Life in Man and Animals, Proc. Quadrennial Int. Conf. Cancer, Perugia Univ. Press, Perugia, 1979, pp. 873-892.
98. Nomura T. Parental exposure to X-rays and chemicals induce heritable tumours and anomalies in mice. Nature. 296:1982;575-577.
99. Nomura T. X-ray and chemically induced germ-line mutation causing phenotypical anomalies in mice. Mutat. Res. 198:1988;309-320.
100. Nomura T. Congenital malformations as a consequence of parental exposure to radiations and chemicals in mice, Proc. Int. Conf. Industrial Health and the VIII UOEH Int. Symp. - Health Surveillance of Workers -. J. Univ. Occup. Environ. Health. 11:1989;406-411.
101. T. Nomura, Male-mediated teratogenesis: ionizing radiation/ethylnitrosourea studies, in: D.R. Mattison, A.f. Olshan (Eds.), Male-mediated Developmental Toxicity, Plenum, New York, 1994, pp. 117-127.
102. Kirk K.M., Lyon M.F. Induction of congenital malformations in in the offspring of female mice exposed to varying doses of X-rays. Mutat. Res. 106:1982;73-83.
103. Kirk K.M., Lyon M.F. Induction of congenital malformations in the offspring of male mice treated with X-rays at pre-meiotic and post-meiotic stages. Mutat. Res. 125:1984;75-85.
104. Lyon M.F., Renshaw R. Induction of congenital malformations in the offspring of mutagen-treated mice. Prog. Clin. Biol. Res. 209B:1986;449-458.
105. Rutledge J.C., Cain K.T., Hughes L.A.et al. Differences between two hybrid stocks of mice in the incidence of congenital abnormalities following X-ray exposure of stem-cell spermatogonia. Mutat. Res. 163:1986;299-302.
106. A.G. Searle and C. Beechey, The role of dominant visibles in mutagenicity testing, in: C. Ramel, et al. (Eds.), Genetic Toxicology of Environmental Chemicals, Part B, Genetic Effects and Applied Mutagenesis, Alan Liss, 1986, pp. 511-518.
107. Cattanach B.M., Burtenshaw M.D., Rasberry C.et al. Large deletions and other gross forms of chromosomal imbalance compatible with viability and fertility in the mouse. Nat. Genet. 3:1993;56-61.
108. B.M. Cattanach, E.P. Evans, C. Rasberry et al., Incidence and distribution of radiation-induced large deletions in the mouse, in: U. Hagan et al. (Eds.), Radiation Research 1895-1995, Proc. 10th Int. Cong. Rad. Res, Würzburg, 1995, pp. 531-534.
109. Lyon M.F., Renshaw R. Induction of congenital malformations in mice by parental irradiation: transmission to later generations. Mutat. Res. 198:1988;277-283.
110. J.V. Neel, S.E. Lewis, The comparative radiation genetics of humans and mice, Ann. Rev. Genet., 24, 1990, 327-262.
111. Henikoff S., Greene E.A., Pietrokovski S.et al. Gene families: the taxonomy of protein paralogs and chimeras. Science. 278:1997;609-614.
112. Akarsu N.A., Stoilov I., Yilmaz E.et al. Genomic structure of HOXD13 gene: a nine polyalanine duplication causes synpolydactyly in two unrelated families. Hum. Mol. Genet. 5:1997;945-952.
113. Bates G., Lehrbach H. Trinucleotide repeat expansions and human genetic disease. BioEssays. 16:1994;277-284.
114. Brais B., Bouchard J.P., Xie Y.G.et al. Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat. Genet. 18:1998;164-167.
115. Campuzano V., Montermini L., Molto M.D.et al. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science. 271:1996;1423-1427.
116. David G., Abbas N., Stevanin G.et al. Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nat. Genet. 17:1997;65-70.
117. Gouw L.G., Castañada M.A., McKenna C.K.et al. Analysis of dynamic mutation in the SCA7 gene shows marked parental effects on CAG repeat transmission. Hum. Mol. Genet. 7:1998;525-532.
118. Koide R., Ikeuchi T., Onodera O.et al. Unstable expansion of CAG repeat in hereditary dentatopallidoluysian atrophy (DRPLA). Nat. Genet. 6:1994;9-13.
119. Knight S.J.L., Voelckel M.A., Hirst M.C.et al. Triplet repeat expansion at the FRAXE locus and X-linked mild mental handicap. Am. J. Hum. Genet. 55:1994;81-86.
120. Maruyama H., Nakamura S., Matsuyama Z.et al. Molecular features of the CAG repeats and clinical manifestations of Machado-Joseph disease. Hum. Mol. Genet. 4:1995;807-812.
121. R.D. Wells, S.T. Warren (Eds.), Genetic Instabilities and Hereditary Neurological Diseases, Academic Press, New York, 1998.
122. 1A-voltage-dependent calcium channel. Nat. Genet. 15:1997;62-69.
123. Lalioti M.D., Scott H.S., Genton P.et al. A PCR amplification method reveals instability of the dodecamer repeat in progressive myoclonus epilepsy (EPM1) and no correlation between the size of the repeat and age of onset. Am. J. Hum. Genet. 62:1998;842-847.
124. Searle A.G. Mutation induction in mice. Adv. Radiat. Biol. 4:1974;131-207.
125. Lyon M.F., King T.R., Gondo Y.et al. Genetic and molecular analysis of recessive alleles at the pink-eyed dilution (p) locus of the mouse. Proc. Nat. Acad. Sci USA. 89:1992;6968-6972.
126. Hosoda K., Hammer K.E., Richardson J.A.et al. Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice. Cell. 79:1994;1267-1276.
127. O'Brien T.P., Metallinos D.L., Chen H.et al. Complementation mapping of skeletal and central nervous system abnormalities in mice of the piebald deletion complex. Genetics. 143:1996;447-461.
128. Bultman S.J., Michaud E.J., Woychik R.P. Molecular chracterisation of the mouse agouti locus. Cell. 71:1992;1195-1204.
129. Ruppert S., Müller G., Kwon B.S., Schütz G. Multiple transcripts of the mouse tyrosinase gene are generated by alternative splicing. EMBO J. 7:1988;2715-2722.
130. Copeland N.G., Gilbert D.J., Cho B.C.et al. Mast cell growth factor maps near the Steel locus on mouse chromosome 10 and is deleted in a number of Steel alleles. Cell. 63:1990;175-183.
131. Jackson I.J. Molecular and developmental genetics of mouse coat color. Ann. Rev. Genet. 28:1994;189-217.
132. Epstein D.E., Malo D., Vekemans M., Gros P. Molecular characterization of a deletion encompassing the Splotch mutation on mouse chromosome 1. Genomics. 10:1991;89-93.
133. Epstein D.E., Vekemans M., Gros P. Splotch (Sp2H), a mutation affecting development of the mouse neural tube, shows a deletion within the paired homeodomain of Pax-3. Cell. 67:1991;767-774.
134. Goulding M., Sterrer S., Fleming J.et al. Analysis of the Pax-3 gene in the mouse mutant Splotch. Genomics. 17:1993;355-363.
135. Bedell M.A., Cleveland L.S., O'Sullivan T.N.et al. Deletion and interallelic complementation analysis of Steel mutant mice. Genetics. 142:1996;935-944.
136. Meuth M. The structure of mutation in mammalian cells. Biochim. Biophys. Acta. 1032:1990;1-17.
137. Vrieling H., Simons J.W., Arwert F.et al. Mutations induced by X-rays at the HPRT locus in cultured Chinese hamster cells are mostly large deletions. Mutat. Res. 144:1985;281-286.
138. Fuscoe J.C., Ockey C.H., Fox M. Molecular analysis of X-ray-induced mutations at the HPRT locus in V79 Chinese hamster cells. Int. J. Rdiat. Biol. 49:1986;1011-1020.
139. Bao C.Y., Ma A.H., Evans H.H.et al. Molecular analysis of HPRT gene mutations induced by α and X-radiation in human lymphoblastoid cells. Mutat. Res. 326:1995;1-15.
140. - mutants. Mutat. Res. 349:1996;33-41.
141. Colussi N., Lohman P.H.M. Low dose-rate X-irradiation induces larger deletions at the human HPRT locus than high dose-rate X-irradiation. Int. J. Radiat. Biol. 72:1997;531-536.
142. Morris T., Masson W., Singleton B.et al. Analysis of large deletions in the HPRT gene of primary human fibroblasts using the polymerase chain reaction. Somat. Cell Mol. Genet. 19:1993;9-19.
143. Nelson S.L., Jones I.M., Fuscoe J.C.et al. Mapping the end points of large deletions affecting the HPRT locus in human peripheral blood cells and cell lines. Radiat. Res. 141:1995;2-10.
144. Bradley W.E.C., Belouchi A., Messing K. The aprt heterozygote/homozygote systems for screening mutagenic agents allows detection of large deletions. Mutat. Res. 199:1993;131-138.
145. Yandell D.W., Dryja T.P., Little J.B. Somatic mutations at a heterozygous autosomal locus in human cells occur more frequently by allele loss than by intragenic structural alteration. Somat. Cell. Mol. Genet. 12:1986;255-263.
146. Yandell D.W., Dryja T.P., Little J.B. Molecular genetic analysis of recessive mutations at a heterozygous autosomal locus in human cells. Mutat. Res. 229:1990;89-102.
147. Li C.-Y., Yandell D.W., Little J.B. Molecular mechanisms of spontaneous and induced loss of heterozygosity. Somat. Cell. Mol. Genet. 18:1992;77-87.
148. Chaudhry M.A., Jiang Q., Ricanti M.et al. Characterization of multilocus deletions in human cells exposed to X-radiation and radon. Radiat. Res. 145:1996;31-38.
149. Fujimori A., Tachibana A., Tatsumi K. Allelic losses at the aprt locus of human lymphoblastoid cells. Mutat. Res. 269:1992;55-62.
150. Miles C., Sargent G., Phear G.et al. DNA sequence analysis of γ-ray-induced deletions and insertions at the aprt locus of Chinese hamster cells. Mol. Carcinog. 3(1992):1990;233-242.
151. Turker M.S., Pieretti M., Kumar S. Molecular evidence for the induction of large interstitial deletions on mouse chromosome 8 by ionizing radiation. Mutat. Res. 374:1997;201-208.
152. Barrios L., Miro R., Caballin M.R.et al. Cytogenetic effects of radiotherapy breakpoint distribution in induced chromosome aberrations. Cancer Genet. Cytogenet. 41:1989;61-70.
153. Thacker J., Fleck E.W., Morris T.et al. Localization of deletion breakpoints in radiation-induced mutants of the hprt gene in hamster cells. Mutat. Res. 232:1990;163-170.
154. Morgan T.L., Fleck E.W., Poston K.A.et al. Molecular characterization of X-ray-induced mutations at the HPRT locus in plateau-phase Chinese hamster cells. Mutat. Res. 232:1990;171-182.
155. Smit A.F.A. The origin of interspersed repeats in the human genome. Curr. Opin. Genet. Develpt. 6:1996;743-748.
156. V.A. McKusick, Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.nlm. Nih.gov/Omim, 1999.
157. Watkins H., Seidman J.G., Seidman C.G.et al. Familial hypertrophic cardiomyopathy: a genetic model for cardiac hypertrophy. Hum. Mol. Genet. 4:1995;1721-1727. Review.
158. Pasini B., Borello M.G., Greco A.et al. Loss of function effect of RET mutations causing Hirschsprung disease. Nat. Genet. 10:1995;35-40.
159. Little M., Holmes G., Pell L.et al. DNA binding capacity of the WT1 protein is abolished by Denys-Drash syndrome WT1 point mutations. Hum. Mol. Genet. 4:1995;351-358.
160. Little M., Wells C. A clinical overview of WT1 gene mutations. Hum. Mutat. 9:1997;209-225.
161. Shalaby F.Y., Levesque P.C., Yang W.P.et al. Dominant negative KvLQT1 mutations underlie the LQT1 form of long QT syndrome. Circulation. 96:1997;1733-1736.
162. Demolombe S., Baro I., Pereon Y.et al. A dominant negative isoform of the long QT syndrome 1 gene product. J. Biol. Chem. 273:1998;6837-6843.
163. Mohammad-Panah R., Demolombe S., Neyroud N.et al. Mutations in a dominant negative isoform correlate with phenotype in inherited arrhythmias. Am. J. Hum. Genet. 64:1999;1015-1023.
164. Ambrose C.M., Duyao M.P., Barnes G.et al. Structure and expression of the Huntington's disease gene: evidence against simple inactivation due to an expanded CAG repeat. Somat. Cell. Mol. Genet. 20:1994;27-38.
165. Mulligan L.M., Eng C., Healy C.S.et al. Specific mutations of the RET protooncogene are related to disease phenotypes in MEN2A and FMTC. Nat. Genet. 6:1994;70-74.
166. Eng C., Smith D.P., Mulligan L.M.et al. Point mutation within the tyrosine kinase domain of the RET protooncogene in multiple endocrine neoplasia type 2B and related sporadic tumours. Hum. Mol. Genet. 3:1994;237-241.
167. McClatchey A.I., McKenna-Yasek D., Cros D.et al. Novel mutations in families with unusual and variable disorders in the skeletal muscle sodium channel. Nat. Genet. 2:1992;148-152.
168. Heine R., Pika U., Lehmann-Horn F. A novel SCN4A mutation causing paramyotonia aggravated by cold and potassium. Hum. Mol. Genet. 2:1993;1349-1353.
169. Meyer-Kleine C., Otto M., Zoll B., Koch M.C. Molecular and genetic characterization of German families with paramyotonia congenita and demonstration of a founder effect in the Ravensburg families. Hum. Genet. 93:1994;707-710.
170. Tahmoush A.J., Schaller K.L., Zhang P. Muscle sodium channel inactivation defect in paramyotonia congenita with thr1313 to met mutation. Neuromuscular Disord. 4:1994;447-454.
171. Muneke M., Schell U. Fibroblast growth factor receptor mutations in human skeletal disorders. Trends Genet. 11:1995;308-313.
172. Yoshimoto Y., Neel J.V., Schull W.J.et al. Malignant tumors during the first two decades of life in the offspring of atomic bomb survivors. Am. J. Hum. Genet. 46:1990;1041-1052.
173. J.V. Neel, W.J. Schull, The Effect of Exposure to the Atomic Bombs on Pregnancy Termination in Hiroshima and Nagasaki, Nat. Acad. Sci. -Nat. Res. Council, Pub. 461, Washington, DC, 1956.
174. Byrne J., Mulvihill J.J., Myers M.H.et al. Effects of treatment on fertility in long-term survivors of childhood or adolescent cancer. New Engl. J. Med. 317:1987;1315-1321.
175. Bellus G.A., Hefferon T.W., de Luma R.I.O.et al. Achondroplasia defined by a recurrent G380R mutation in FGFR3. Am. J. Hum. Genet. 56:1995;368-373.
176. Bellus G.A., McIntosh I., Smith E.A. A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochrodroplasia. Nat. Genet. 10:1995;357-359.
177. Rousseau F., Bonaventure J., Legeal-Mallet L.et al. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature. 371:1994;252-253.
178. Shiang R., Thompson L.M., Zhu Y.Z.et al. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell. 78:1993;338-342.
179. Tavormina P.L., Shiang R., Thompson L.M.et al. Thanatophoric dysplasia (types I and II) caused by distinct mutations in the fibroblast growth factor receptor 3. Nat. Genet. 9:1995;321-328.
180. Wilkie A.O.M., Slaney S.F., Oldridge M.et al. Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nat. Genet. 9:1995;165-172.
181. Oldridge M., Zachai E.H., McDonald-McGinn D.M.et al. De novo Alu-element insertions in FGFR2 identify a distinct pathological basis for Apert syndrome. Am. J. Hum. Genet. 64:1999;446-461.
182. Deng C.X., Wynshaw-Boris A., Shen et al M.M. Murine Fgfr-1 is required for early post-implantation growth and axial organization. Genes Dev. 8:1994;3045-3057.
183. Deng C.X., Wynshaw-Boris A., Zhou F.et al. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell. 84:1996;911-921.
184. T.P. Yamaguchi, K. Harpal, M. Henkemeyer, et al., Fgfr-1 is required for embryonic growth and mesodermal patterning during mouse gastrulation, Gene. Dev. (1994) 3032-3044.
185. Brook J.D., McCurrach M.E., Harley H.G.et al. Molecular basis of myotonic dystrophy. Cell. 68:1992;799-808.
186. Fu Y.H., Pizzuti A., Fenwick R.G.et al. An unstable repeat in a gene related to myotonic dystrophy. Science. 255:1992;1253-1255.
187. Mahadevan M.S., Tsilfidis C., Sabourin L.et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 3′ untranslated region of the gene. Science. 255:1992;1253-1255.
188. Harris S., Moncrieff C., Johnson K. Mytonic dystrophy: will the real gene please step forward? Hum. Mol. Genet. 5:1996;1417-1423. Review.
189. Winchester C.L., Ferrier R.K., Sermoni A.et al. Characterization of the expression of DMPK and SIX5 in the human eye and implications for pathogenesis in myotonic dystrophy. Hum. Mol. Genet. 8:1999;481-492.
190. Pereira L., D'Alessio M., Ramirez F.et al. Genomic organization of the sequence coding for fibrillin, the defectivew gene product in Marfan syndrome. Hum. Mol. Genet. 2:1993;961-968.
191. Dietz H.C., Pyeritz R.E. Mutations in the human gene for fibrillin-1 in the Marfan syndrome and related disorders. Hum. Mol. Genet. 4:1995;1799-1809. Review.
192. El Ghouzzi V., Le Merrer M., Perrin-Schmitt F.et al. Mutations in the TWIST gene in the Saethre-Chotzen syndrome. Nat. Genet. 15:1997;42-46.
193. Johnson D., Horsley S.W., Moloney D.M.et al. A comprehensive screen for TWIST mutations in patients with cranisynostosis identfies a new microdeletion syndrome of chromosome band 7p21.1. Am. J. Hum. Genet. 63:1998;1282-1291.
194. Hastie N.D. The genetics of Wilms' tumor - a case of disrupted development. Ann. Rev. Genet. 28:1994;523-558.
195. Hanson I., Van Heyningen V. PAX6: more than meets the eye. Trends Genet. 11:1995;268-272.
196. Nagase H., Nakamura Y. Mutations of the adenomatous polyposis (APC) gene. Hum. Mutat. 2:1993;425-434.
197. Upadhyaya M., Maynard J., Osborn M.et al. Characterisation of germline mutations in the neurofibromatosis 1 (NF1) gene. J. Med. Genet. 32:1995;706-710.
198. Upadhyaya M., Osborn M.J., Maynard J.et al. Mutational and functional analysis of neurofibromatosis 1 (NF1) gene. Hum. Genet. 99:1997;88-92.
199. Bourn D., Carter S.A., Mason S.et al. Germline mutations in the neurofibromatosis 2 (NF2) gene. Hum. Mol. Genet. 3:1994;813-816.
200. Ruttledge M.H., Andermann A.A., Phelan C.M.et al. Type of mutation in the neurofibromatosis 2 (NF2) gene frequently determines severity of disease. Am. J. Hum.Genet. 59:1996;331-342.
201. Lohmann D.R., Brandt B., Hopping W.et al. The spectrum of RB1 germline mutations in hereditary retinoblastoma. Am. J. Hum. Genet. 58:1996;940-949.
202. International Polycystic Kidney Consortium Polycystic kidney disease: the
203. Watnick T.J., Piontek K.B., Cordal T.M. An unusual pattern of mutations in the duplicated region of the protein of PKD1 is revealed by the use of a novel strategy for mutation detection. Hum. Mol. Genet. 6:1997;1473-1481.
204. Harris P.C., Ward C.J., Peral B., Hughes J. Autosomal dominant polycystic kidney disease: molecular analysis. Hum. Mol. Genet. 4:1995;1745-1749. Review.
205. Mochizuki T., Wu G., Hayashi T.et al. PKD2 - a gene for polycystic kidney disease that encodes an integral membrane protein. Science. 272:1996;1339-1342.
206. Hayashi T., Mochizuki T., Reynolds D.M. Characterization of the exon structure of the polycystic kidney disease 2 (PKD2). Genomics. 44:1997;131-136.
207. Chen Z.Y., Denney R.M., Breakfield X.O. Norrie disease and MAO genes: nearest neighbors. Hum. Mol. Genet. 4:1995;1729-1737. Review.
208. Wright T.J., Ricke D.O., Denison K.et al. A transcript map of the newly defined 165 kb Wolf-Hirschhorn syndrome critical region. Hum. Mol. Genet. 6:1997;317-324.
209. Wright T.J., Clemens M., Quarrell O., Arthur M.R. Wolf-Hirschhorn and Pitt-Rogers-Danks syndromes caused by overlapping 4p deletions. Am. J. Med. Genet. 75:1998;345-350.
210. Altherr M.R., Wright T.J., Denison K.et al. Delimiting the Wolf-Hirschhorn syndrome critical region. Am. J. Med. Genet. 71:1997;47-53.
211. Overhauser J., Huang X., Gersh M.et al. Molecular and phenotypic mapping of the short arm of chromosome 5: sublocalization of the critical region for the cri du chat syndrome. Hum. Mol. Genet. 3:1994;247-252.
212. Lowery M.C., Morris C.A., Ewart A.et al. Strong correlation of elastin deletions, detected by FISH with Williams syndrome. Evaluation with 235 patients. Am. J. Hum. Genet. 57:1995;49-53.
213. Nickerson E., Greenberg F., Keating M.T.et al. Deletions of the elastin gene at 7q11.23 occur in approximately 90% of patients with Williams syndrome. Am. J. Hum. Genet. 56:1995;1156-1161.
214. Dutty F., Schinzel A. Unequal interchromosomal rearrangements may result in elastin gene deletions causing the Williams-Beuren syndrome. Hum. Mol. Genet. 5:1996;1893-1898.
215. Perez-Jurado L.A., Peoples R., Kaplan P.et al. Molecular definition of chromosome 7 deletions in Williams syndrome and parent-of-origin effects on growth. Am. J. Hum. Genet. 59:1996;781-792.
216. Monaco A.P. Human genetics: dissecting Williams syndrome. Curr. Biol. 6:1996;1396-1398.
217. Roessler E., Belloni E., Gaudenz K.et al. Mutations in the human Sonic Hedgehog gene causes holoprosencephaly. Nat. Genet. 14:1996;357-360.
218. Roessler E., Ward D.E., Gaudenz K.et al. Cytogenetic rearrangements involving loss of the Sonic Hedgehog gene at 7q36 cause holoprosencephaly. Hum. Genet. 100:1997;172-181.
219. Hou J., Parrish J., Lüdecke H.J.et al. A 4-Mb contig that spans the Langer-Giedion syndrome region on human chromosome 8q24.1. Use in refining the location of the trichorhinophalangeal syndrome and multiple exotoses genes (TRPS1 and EXT1). Genomics. 29:1995;87-97.
220. Lüdecke H.J., Wagner M.J., Nordmann J.et al. Molecular dissection of a contiguous gene syndrome: localization of the genes involved in Langer-Giedion syndrome. Hum. Mol. Genet. 4:1995;31-36.
221. Hastie N.D. The genetics of Wilms' tumor - a case of disrupted development. Ann. Rev. Genet. 28:1994;523-558.
222. Hanson I., Van Heyningen V. PAX6: more than meets the eye. Trends Genet. 11:1995;268-272.
223. Penny L.A., Dell'Aquila M., Jones M.C.et al. Clinical and molecular characterization of patients with distal 11q deletions. Am. J. Hum. Genet. 56:1995;676-683.
224. Michaelis R.C., Velagelati G.V.N., Jones C.et al. Most Jacobsen syndrome deletion breakpoints occur distal to FRA11B. Am. J. Med. Genet. 76:1998;222-228.
225. Mutirangura A., Jayakumar A., Sutcliffe J.S.et al. A complete YAC contig of the Prader-Willi/Angelman chromosome region (15q11-q13) and refined localization of the SNRPN gene. Genomics. 18:1993;546-552.
226. Christian S.L., Bhatt N.H., Martin S.A.et al. Inegrated YAC contig map of the Prader-Willi/Angelman region on chromosome 15q11-q13 with average STS spacing of 35 kb. Genome Res. 8:1998;146-157.
227. Matsuura T., Sutcliffe J.S., Fang P.et al. De novo truncating mutations in E6-AP ubiquitin protein gene (UBE3A) in Angelman syndrome. Nat. Genet. 15:1997;74-77.
228. Kishino T., Lalande M., Wagstaff J. UBE3A/E6-AP mutations cause Angelman syndrome. Nat. Genet. 15:1997;70-73.
229. Petrij F., Giles R.H., Dauwerse H.G.et al. Rubinstein-Taybi syndrome caused by mutation in the transcriptional co-activator CBP. Nature. 376:1995;348-351.
230. Brook-Carter P.T., Peral B., Ward C.J.et al. Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease - a contiguous gene syndrome. Nat. Genet. 8:1994;328-332.
231. Wilkie A.O.M., Buckle V.J., Harris P.C.et al. Clinical features and molecular analysis of the α thalassemia/mental retardation syndrome: I. cases due to deletions involving chromosome band 16p13.3. Am. J. Hum. Genet. 46:1990;1112-1126.
232. Lindor N.M., Valdes M.G., Wick M.et al. De novo deletion: ATR-16 syndrome. Am. J. Med. Genet. 72:1997;451-454.
233. Reiner O., Carrozo R., Shen Y.et al. Isolation of a Miller-Dieker lissencephaly gene containing G protein beta subunit-like repeats. Nature. 364:1992;717-721.
234. Chong S.S., Pack S.D., Roschke A.V.et al. A revision of the lissencephaly and Miller-Dieker syndrome critical regions in chromosome 17p13.3. Hum. Mol. Genet. 6:1997;147-155.
235. Juyal R.C., Greenberg F., Mengden G.A.et al. Smith-Magenis syndrome deletion: a case with equivocal cytogenetic findings resolved by fluorescence in situ hybridization. Am. J. Med. Genet. 58:1996;286-291.
236. Trask B.J., Medford H., Engh G.V.D.et al. Quantification by flow cytometry of chromosome 17 deletions in Smith-Magenis syndrome patients. Hum. Genet. 98:1997;710-718.
237. Park J.R., Mueschler J.B., Davies W.S.et al. Smith-Magenis syndrome resulting from a de novo direct insertion of proximal 17q into 17p11.2. Am. J. Med. Genet. 77:1998;23-27.
238. Li L., Krantz I.D., Yu D.et al. Alagille syndrome is caused by mutations in Jagged1, a ligand for Notch 1. Nat. Genet. 16:1997;243-250.
239. Driscoll D.A., Emanuel B.S. Di George and velocardiofacial syndromes: the 22q11 deletion syndrome. Ment. Retard. Dev. Disab. Res. Rev. 2:1996;130-138.
240. Shapira S.K., McCaskill C.M., Northrup H.et al. Chromosome 1p36 deletions: the clinical phenotype and molecular characterization of a common newly delineated syndrome. Am. J. Hum. Genet. 61:1997;642-650.
241. Sander A., Schmelzle R., Murray J. Evidence for a microdeletion in the 1q32-41 involving the gene responsible for Van der Woude syndrome. Hum. Mol. Genet. 3:1994;575-578.
242. Schutter B.C., Sander A., Malik M., Murray J.C. Refinement of the Van der Woude syndrome gene location and construction of a 3.5 Mb YAC contig and STS map spanning the critical region 1q32-q41. Genomics. 36:1996;507-514.
243. Schell U., Weinberg J., Kohler A.et al. Molecular characterization of breakpoints in patients with holoprosencephaly and definition of the HPE2 critical region 2p21. Hum. Mol. Genet. 5:1996;223-229.
244. Schinzel A., Gundelfinger R., Dutly F.et al. A 5-year old girl with interstitial deletion of 3p14: clinical, psychologic, cytogenetic and molecular studies. Am. J. Med. Genet. 77:1998;302-305.
245. Fryns J.P., Stromme P., Van den Berg H. Further evidence for the location of the blepharophimosis syndrome (BPES) at 3q22.3-q23. Clin. Genet. 44:1993;149-151.
246. Ishikiriyama S., Goto M. Blepharophimosis, ptosis and epicanthus inversus syndrome (BPES) and microcephaly. Am. J. Med. Genet. 52:1994;245. letter.
247. Warburg M., Bugge M., Brondum-Nelson K. Cytogenetic findings indicate heterogeneity in patients with blepharophimosis, epicanthus inversus and developmental delay. J. Med. Genet. 32:1995;19-24.
248. Fujimoto A., Reddy K.S., Spinks R. Interstitial deletion of chromosome 4, del(4)(q12q-21.1), in a mentally retarded boy with a piebald trait, due to maternal insertion, ins(8;4). Am. J. Med. Genet. 75:1998;78-81.
249. Courtens W., Tjalma W., Messiaen L.et al. Prenatal diagnosis of a constitutional interstitial deletion of chromosome 5 (q15q31.1) presenting with features of congenital contractural arachnodactyly. Am. J. Med. Genet. 77:1998;188-197.
250. Garcia-Esquivel L., Garcia-Cruz D., Rivera H.et al. De novo del(7)(pter-p21.2-p15.2-qter) and craniosynostosis: implications for critical segment assignment in the 7p21 monosomy syndrome. Ann. Genet. 29:1986;36-38.
251. Johnson D., Horsley S.W., Maloney D.M.et al. A comprehensive screen for TWIST mutations in patients with craniosynostosis identifies a new microdeletion syndrome of chromosome band 7p21.1. Am. J. Hum. Genet. 63:1998;1282-1293.
252. Vincent C., Kalatzis V., Compain S.et al. A proposed new contiguous gene syndrome on 8q consists of a Branchio-Oto-Renal (BOR) syndrome, Duane syndrome, a dominant form of hydrocephalus and trapeze aplasia: implications for the mapping of the BOR gene. Hum. Mol. Genet. 3:1994;1859-1866.
253. Calabrese G., Stuppia L., Franchi P.G.et al. Detection of an insertion deletion of region 8q13-q21.2 in a patient with Duane syndrome: implications for mapping and cloning of a Duane gene. Eur. J. Hum. Genet. 6:1998;187-193.
254. Povey S., Atwood J., Chadwick B.et al. Report of the fifth International Worshop on chromosome 9. Ann. Hum. Genet. 61:1997;183-206.
255. Shimkets R., Gailani M.R., Siu V.M.et al. Molecular analysis of chromosome 9q deletions in two Gorlin syndrome patients. Am. J. Hum. Genet. 59:1996;417-422.
256. Petersen B., Strassburg H.M., Feichtinger W.et al. Terminal deletion of the long arm of chromosome 10: a new case with breakpoints in q25.3. Am. J. Med. Genet. 77:1998;60-62.
257. Bartsch O., Wuyts W., Van Hul W.et al. Delineation of a contiguous gene syndrome with multiple exotoses, enlarged parietal foramina, craniofacial dysostosis and mental retardation, caused by deletions on the short arm of chromosome 11. Am. J. Hum. Genet. 58:1996;734-742.
258. Potocki L., Shaffer L.G. Interstitial deletion of 11(p11.2-p12): a newly described contiguous gene deletion syndrome involving the gene for heredtiary multiple exotoses (EXT2). Am. J. Med. Genet. 62:1996;319-325.
259. Brown S., Russo J., Chitayat D., Warburton D. The 13q-syndrome: the molecular definition of a critical region in band 13q32. Am. J. Hum. Genet. 57:1995;859-866.
260. Lemyre E., Lemieux N., Decarie J.C., Lambert M. Del(14)(q22.1-q23.1) in a patient with anophthalmia and pituitary hypoplasia. Am. J. Med. Genet. 77:1998;162-165.
261. Kline A.D., White M.E., Wapner R.et al. Molecular analysis of the 18q-syndrome and correlation with phenotype. Am. J. Hum. Genet. 52:1993;895-906.
262. Silverman G.A., Schneider S.S., Massa H.F.et al. The 18q-syndrome: analysis of chromosome by bivariate flow karyotyping and the PCR reveals a successive set of deletion breakpoints within 18q21.2-q22.2. Am. J. Hum. Genet. 56:1995;926-937.
263. Strathdee G., Sutherland R., Jonsson J.J.et al. Molecular characterization of patients with 18q23 deletions. Am. J. Hum. Genet. 60:1997;860-868.
264. Cody J.D., Hale D.E., Brkanac Z.et al. Growth hormone insufficiency associated with haploinsufficiency at 18q23. Am. J. Med. Genet. 71:1997;420-425.
265. Gustavsson P., Garelli B., Draptchinskaia N.et al. Identification of microdeletion spanning the Diamond-Blackfan anemia locus on 19q13 and evidence for genetic heterogeneity. Am. J. Hum. Genet. 63:1998;1388-1395.
266. Wong A.C.C., Ning Y., Flint J.et al. Molecular characterization of a 130-kb terminal microdeletion at 22q in a child with mild mental retardation. Am. J. Hum. Genet. 60:1997;113-120.